A novel PD-1/PD-L1 pathway molecular typing-related signature for predicting prognosis and the tumor microenvironment in breast cancer
Abstract Background Currently, the development of breast cancer immunotherapy based on the PD-1/PD-L1 pathway is relatively slow, and the specific mechanism affecting the immunotherapy efficacy in breast cancer is still unclear. Methods Weighted correlation network analysis (WGCNA) and the negative...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2023-05-01
|
Series: | Discover Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1007/s12672-023-00669-4 |